Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.

ClinicalTrials.gov 4 recruiting now early-phase tilt small index

Spondylosis: early-phase trial registry

4 of 9 indexed Spondylosis trials are currently recruiting, with more weight in Phase 1-2.

Corpus placement: #1,916 of 28,707 conditions by registered trial count.

9 US clinical trials · 4 currently recruiting · #1,916 of 28,707 conditions by registered trial count

Spondylosis: 9 US clinical trials tracked, 4 recruiting.

Spondylosis is the subject of 9 registered US clinical trials on ClinicalTrials.gov, 4 of them currently open to new participants. 0 are in Phase 3-4 (later-stage) and 1 in Phase 1-2 (earlier-stage). The most active sponsor is SeaSpine, running 2 of these trials.

Enrollment posture brief

Registry condition spondylosis

OPEN 4 | RECR 44% | LATE 0 | EARLY 1 | RANK #1916 | SPON 2

Nearest open-share peer: Acute Ischemic Stroke (44% recruiting · 27 trials)

Acute Lymphoblastic Leukemia55.6%Acute Respiratory Distress S55.6%Spondylosis (this)44%Acute Otitis Media22.2%Acute Heart Failure11.1%
Open-enrollment share among volume-matched conditions near Spondylosis

Spondylosis lists 4 open slots (44% of 9 indexed trials). Peers are matched on registered volume, not therapeutic-area browse lists. How peer matching works →

Key findings

What ClinicalTrials.gov does not surface for Spondylosis on its own pages , computed from the registry mirror as of 2026-08-08. Each line carries its own denominator so it can be quoted as it stands.

  1. Spondylosis is recruiting below its size-band peers.

    4 of 9 indexed trials (44.4%) are open to enrollment, against a 46.5% average across 27,806 conditions with fewer than 20 trials. The peer set uses the same ClinicalTrials.gov-derived counts as this page.

  2. One sponsor concentrates Spondylosis research.

    SeaSpine accounts for 2 of 9 trials (22.2%). 8 distinct sponsors appear on at least one study for this condition label.

  3. Most Spondylosis trials plan to enrol fewer than 100 people.

    Median target enrolment is 45 among the 9 trials that report a genuine target (sentinel values excluded). 7 of those (77.8%) plan for fewer than 100 participants.

  4. Spondylosis research is mostly interventional.

    9 interventional and 0 observational studies make up this index (100% interventional). Study type is sponsor-reported on ClinicalTrials.gov.

Phase 11

Phase Distribution

PhaseTrial count
Phase 1 1

Named interventions

Most-linked intervention names on Spondylosis records (sponsor-reported on ClinicalTrials.gov). Counts are trial links, not unique products.

rh-BMP2 Device
1 trials
NuCel with Autograft Other
1 trials
Posterolateral Fusion Procedure
1 trials
map3® Cellular Allogeneic Bone Graft Other
1 trials
epidural electrical stimulation Device
1 trials
CEM-Plate Anterior Cervical Plating System and CEM-Cage Cervical Interbody System Device
1 trials
ACT intervention Behavioral
1 trials
Placebo oral tablet Drug
1 trials

US sites by state

Facility locations filed on Spondylosis trials. A trial with sites in several states counts in each.

New York 3 trials
Ohio 2 trials
Massachusetts 2 trials
California 2 trials
New Jersey 1 trials
North Carolina 1 trials
Georgia 1 trials

Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.

What to do with this Spondylosis page

9 registered trials, 4 currently recruiting, is a starting point for a conversation, not a diagnosis or a recommendation.

  • 4 Spondylosis trials are currently recruiting, check eligibility criteria before contacting a site. Browse recruiting trials
  • SeaSpine sponsors the most Spondylosis trials on record, review their full trial history before evaluating a specific study. See SeaSpine's trials
  • Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide

Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This Spondylosis condition card totals 9 registered trials; most-linked intervention rh-BMP2; top US site state New York. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.